Alteplase, a tissue plasminogen activator (tPA), is the guideline-recommended IVT agent for eligible acute ischemic stroke (AIS) patients within 4.5 h after the onset of stroke (Berge et al., 2021; Powers et al., 2019). The gene discussed is PLAT; the disease is stroke disorder.